Together, our results indicate that, although the short (GT)n variants in the HO-1 gene promoter may likely be related to a reduced inflammation level, the effect seems not necessarily to confer protection against the development of liver cirrhosis or cancer. The gene discussed is HMOX1; the disease is cancer.